116 related articles for article (PubMed ID: 20447102)
1. Expression of advanced glycation end products and related molecules in diabetic fibrovascular epiretinal membranes.
Abu El-Asrar AM; Missotten L; Geboes K
Clin Exp Ophthalmol; 2010 Jan; 38(1):57-64; quiz 87. PubMed ID: 20447102
[TBL] [Abstract][Full Text] [Related]
2. Expression of hypoxia-inducible factor-1alpha and the protein products of its target genes in diabetic fibrovascular epiretinal membranes.
Abu El-Asrar AM; Missotten L; Geboes K
Br J Ophthalmol; 2007 Jun; 91(6):822-6. PubMed ID: 17229797
[TBL] [Abstract][Full Text] [Related]
3. Circulating bone-marrow-derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes.
Abu El-Asrar AM; Struyf S; Verbeke H; Van Damme J; Geboes K
Acta Ophthalmol; 2011 May; 89(3):222-8. PubMed ID: 19764917
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclo-oxygenase-2 and downstream enzymes in diabetic fibrovascular epiretinal membranes.
El-Asrar AM; Missotten L; Geboes K
Br J Ophthalmol; 2008 Nov; 92(11):1534-9. PubMed ID: 18952655
[TBL] [Abstract][Full Text] [Related]
5. Expression of autotaxin and acylglycerol kinase in proliferative vitreoretinal epiretinal membranes.
Abu El-Asrar AM; Missotten L; Geboes K
Acta Ophthalmol; 2012 Mar; 90(2):e84-9. PubMed ID: 22103573
[TBL] [Abstract][Full Text] [Related]
6. Expression of stem cell factor/c-kit signaling pathway components in diabetic fibrovascular epiretinal membranes.
Abu El-Asrar AM; Struyf S; Opdenakker G; Van Damme J; Geboes K
Mol Vis; 2010 Jun; 16():1098-107. PubMed ID: 20596251
[TBL] [Abstract][Full Text] [Related]
7. Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy.
Kobayashi Y; Yoshida S; Zhou Y; Nakama T; Ishikawa K; Arima M; Nakao S; Sassa Y; Takeda A; Hisatomi T; Ikeda Y; Matsuda A; Sonoda KH; Ishibashi T
Mol Vis; 2016; 22():436-45. PubMed ID: 27186070
[TBL] [Abstract][Full Text] [Related]
8. Expression of thrombospondin-2 as a marker in proliferative diabetic retinopathy.
Abu El-Asrar AM; Nawaz MI; Ola MS; De Hertogh G; Opdenakker G; Geboes K
Acta Ophthalmol; 2013 May; 91(3):e169-77. PubMed ID: 23387388
[TBL] [Abstract][Full Text] [Related]
9. Myofibroblasts in proliferative diabetic retinopathy can originate from infiltrating fibrocytes and through endothelial-to-mesenchymal transition (EndoMT).
Abu El-Asrar AM; De Hertogh G; van den Eynde K; Alam K; Van Raemdonck K; Opdenakker G; Van Damme J; Geboes K; Struyf S
Exp Eye Res; 2015 Mar; 132():179-89. PubMed ID: 25637870
[TBL] [Abstract][Full Text] [Related]
10. Alphab-crystallin expression in epiretinal membrane of human proliferative diabetic retinopathy.
Dong Z; Kase S; Ando R; Fukuhara J; Saito W; Kanda A; Murata M; Noda K; Ishida S
Retina; 2012 Jun; 32(6):1190-6. PubMed ID: 22371118
[TBL] [Abstract][Full Text] [Related]
11. The tumor necrosis factor superfamily members TWEAK, TNFSF15 and fibroblast growth factor-inducible protein 14 are upregulated in proliferative diabetic retinopathy.
Abu El-Asrar AM; De Hertogh G; Nawaz MI; Siddiquei MM; Van den Eynde K; Mohammad G; Opdenakker G; Geboes K
Ophthalmic Res; 2015; 53(3):122-30. PubMed ID: 25676319
[TBL] [Abstract][Full Text] [Related]
12. Expression of high-mobility groups box-1/receptor for advanced glycation end products/osteopontin/early growth response-1 pathway in proliferative vitreoretinal epiretinal membranes.
El-Asrar AM; Missotten L; Geboes K
Mol Vis; 2011 Feb; 17():508-18. PubMed ID: 21365018
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.
Tsanou E; Ioachim E; Stefaniotou M; Gorezis S; Charalabopoulos K; Bagli H; Peschos D; Psilas K; Agnantis NJ
Int J Clin Pract; 2005 Oct; 59(10):1157-61. PubMed ID: 16178982
[TBL] [Abstract][Full Text] [Related]
14. Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy.
Limb GA; Chignell AH; Green W; LeRoy F; Dumonde DC
Br J Ophthalmol; 1996 Feb; 80(2):168-73. PubMed ID: 8814750
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy.
Ishida S; Shinoda K; Kawashima S; Oguchi Y; Okada Y; Ikeda E
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1649-56. PubMed ID: 10845581
[TBL] [Abstract][Full Text] [Related]
16. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613
[TBL] [Abstract][Full Text] [Related]
17. Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker.
Armstrong D; Augustin AJ; Spengler R; Al-Jada A; Nickola T; Grus F; Koch F
Ophthalmologica; 1998; 212(6):410-4. PubMed ID: 9787233
[TBL] [Abstract][Full Text] [Related]
18. Expression of angiogenic and fibrogenic factors in proliferative vitreoretinal disorders.
Abu El-Asrar AM; Van den Steen PE; Al-Amro SA; Missotten L; Opdenakker G; Geboes K
Int Ophthalmol; 2007 Feb; 27(1):11-22. PubMed ID: 17375263
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy.
Bochaton-Piallat ML; Kapetanios AD; Donati G; Redard M; Gabbiani G; Pournaras CJ
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2336-42. PubMed ID: 10892881
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
